【摘要】 目的　探讨思密达在宫颈癌放疗所致急性胃肠道反应中的作用。方法　对 78例接受放疗伴有急性胃肠道反应的宫颈癌病人进行治疗观察。随机分成两组 ,A组 (治疗组 ) 40例 ,于出现胃肠反应后予思密达口服治疗每次 3 .0g ,3次 /d ,连服 1周。强地松 ,每次 10mg ,3次 /d ,连服 3d。环丙沙星 0 .1g ,2次 /d ,连服 7d。B组 (对照组 ) 3 8例 ,于出现反应后 ,强地松 10mg ,3次 /d ,连服 5d ;环丙沙星 0 .1g ,2次 /d ,连服 7d。结果　对治疗急性胃肠道反应 ,A组有效率明显高于B组 (P <0 .0 5 )。结论　思密达对治疗宫颈癌放疗引起的急性胃肠道反应有较好的疗效更多还原

【Abstract】 Objective To evaluate the effect of smecta on acute gastroenteritis induced by the radiotherapy in human cervical cancer.Methods seventy-eight patients under radiotherapy received smecta combined with general medicine to control gastroenteritis. All patients were divided into 2 groups:group A: 40 patients were treated with smecta and general medicine.group B:38 patients were only routinely treated. The routine medicine included prednisone, vitamin B 2 and ciprofloxacin.Results The effective rate for acute gastroenteritis in A group was significant higher than in B group ( P <0.05).Conclusion Smecta is effective for acute gastroenteritis induced by the radiotherapy in human cervical cancer.更多还原